Cassava, Annovis among H1 biotech winners while Grayburg, Odonate biggest laggards

Bull and Bear on stock market prices via Getty Images

  • Companies engaged in developing therapies for Alzheimer's disease were among the best performing biotech stocks in the first half of the year.
  • Cassava Sciences (SAVA -1.7%) was the best performing biotech stock in the

Recommended For You

Comments (7)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.